Paula M. Moran

2.3k total citations
63 papers, 1.8k citations indexed

About

Paula M. Moran is a scholar working on Cellular and Molecular Neuroscience, Cognitive Neuroscience and Molecular Biology. According to data from OpenAlex, Paula M. Moran has authored 63 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Cellular and Molecular Neuroscience, 24 papers in Cognitive Neuroscience and 19 papers in Molecular Biology. Recurrent topics in Paula M. Moran's work include Neurotransmitter Receptor Influence on Behavior (25 papers), Memory and Neural Mechanisms (17 papers) and Schizophrenia research and treatment (15 papers). Paula M. Moran is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (25 papers), Memory and Neural Mechanisms (17 papers) and Schizophrenia research and treatment (15 papers). Paula M. Moran collaborates with scholars based in United Kingdom, Ireland and China. Paula M. Moran's co-authors include Paul Moser, Linda S. Higgins, Barbara Cordell, Andrew M. J. Young, Colm O’Tuathaigh, Janice M. Hitchcock, M. H. Joseph, Michael H. Joseph, John L. Waddington and J.A. Gray and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and SHILAP Revista de lepidopterología.

In The Last Decade

Paula M. Moran

62 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Paula M. Moran United Kingdom 22 975 627 528 257 225 63 1.8k
Tori L. Schaefer United States 30 974 1.0× 604 1.0× 589 1.1× 190 0.7× 309 1.4× 63 2.2k
Roberto Stancampiano Italy 24 929 1.0× 348 0.6× 424 0.8× 326 1.3× 381 1.7× 58 1.9k
Stacy A. Castner United States 21 1.1k 1.2× 639 1.0× 601 1.1× 407 1.6× 196 0.9× 31 2.0k
Susana Mingote United States 26 1.7k 1.7× 935 1.5× 752 1.4× 223 0.9× 358 1.6× 33 2.6k
Takeshi Izumi Japan 26 893 0.9× 568 0.9× 472 0.9× 232 0.9× 359 1.6× 84 1.8k
Nader D. Halim United States 12 752 0.8× 635 1.0× 882 1.7× 508 2.0× 144 0.6× 13 2.5k
Gary Gilmour United Kingdom 26 1.0k 1.1× 793 1.3× 591 1.1× 153 0.6× 154 0.7× 58 1.9k
Changhai Cui United States 16 795 0.8× 304 0.5× 663 1.3× 230 0.9× 102 0.5× 20 1.8k
Samantha E. Yohn United States 25 1.1k 1.1× 452 0.7× 496 0.9× 352 1.4× 265 1.2× 46 2.0k
Luigi Pulvirenti United States 28 1.7k 1.8× 387 0.6× 910 1.7× 193 0.8× 196 0.9× 43 2.1k

Countries citing papers authored by Paula M. Moran

Since Specialization
Citations

This map shows the geographic impact of Paula M. Moran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paula M. Moran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paula M. Moran more than expected).

Fields of papers citing papers by Paula M. Moran

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paula M. Moran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paula M. Moran. The network helps show where Paula M. Moran may publish in the future.

Co-authorship network of co-authors of Paula M. Moran

This figure shows the co-authorship network connecting the top 25 collaborators of Paula M. Moran. A scholar is included among the top collaborators of Paula M. Moran based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paula M. Moran. Paula M. Moran is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Maggi, Silvia, Martin O’Neill, Mark J. Buckley, et al.. (2024). Tracking subjects’ strategies in behavioural choice experiments at trial resolution. eLife. 13. 6 indexed citations
2.
O’Neill, Cian, et al.. (2021). Cannabis Use, Schizotypy and Kamin Blocking Performance. Frontiers in Psychiatry. 12. 633476–633476. 2 indexed citations
3.
Collins, Hilary M., Miguel Hernández-Quiles, Elizabeth A. Stewart, et al.. (2017). Heterodimers of photoreceptor-specific nuclear receptor (PNR/NR2E3) and peroxisome proliferator-activated receptor-γ (PPARγ) are disrupted by retinal disease-associated mutations. Cell Death and Disease. 8(3). e2677–e2677. 7 indexed citations
4.
Moran, Paula M., et al.. (2016). Registro más austral del pato picazo ( Netta peposaca : Anseriformes: Anatidae) en Punta Elefante, Antártida. SHILAP Revista de lepidopterología. 184–187. 1 indexed citations
5.
Granger, Kiri, et al.. (2015). Enhanced latent inhibition in high schizotypy individuals. Personality and Individual Differences. 91. 31–39. 17 indexed citations
6.
O’Tuathaigh, Colm, Paula M. Moran, & John L. Waddington. (2013). Genetic models of schizophrenia and related psychotic disorders: progress and pitfalls across the methodological “minefield”. Cell and Tissue Research. 354(1). 247–257. 7 indexed citations
7.
Montiel‐Duarte, Cristina, Hilary M. Collins, Frances Wadelin, et al.. (2013). A signature motif mediating selective interactions of BCL11A with the NR2E/F subfamily of orphan nuclear receptors. Nucleic Acids Research. 41(21). 9663–9679. 18 indexed citations
8.
O’Tuathaigh, Colm, Brian P. Kirby, Paula M. Moran, & John L. Waddington. (2009). Mutant Mouse Models: Genotype-Phenotype Relationships to Negative Symptoms in Schizophrenia. Schizophrenia Bulletin. 36(2). 271–288. 51 indexed citations
9.
Bay-Richter, Cecilie, Colm O’Tuathaigh, Gerard J. O’Sullivan, et al.. (2008). Enhanced latent inhibition in dopamine receptor-deficient mice is sex-specific for the D1 but not D2 receptor subtype: implications for antipsychotic drug action. The International Journal of Neuropsychopharmacology. 12(3). 403–403. 22 indexed citations
10.
Elliott, J.M., et al.. (2006). High-dose MDMA does not result in long-term changes in impulsivity in the rat. Psychopharmacology. 188(1). 75–83. 8 indexed citations
11.
Migo, Ellen M., et al.. (2005). A novel test of conditioned inhibition correlates with personality measures of schizotypy and reward sensitivity. Behavioural Brain Research. 168(2). 299–306. 24 indexed citations
12.
O’Tuathaigh, Colm & Paula M. Moran. (2004). The effect of sulpiride on amphetamine-induced disruption of overshadowing in the rat. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 28(8). 1249–1253. 8 indexed citations
13.
McDonald, Louise, Paula M. Moran, Goparlen N. Vythelingum, et al.. (2003). Enhancement of latent inhibition by two 5-HT2A receptor antagonists only when given at both pre-exposure and conditioning. Psychopharmacology. 169(3-4). 321–331. 5 indexed citations
14.
Moran, Paula M., et al.. (2003). An Investigation Into Age and Gender Differences in Human Kamin Blocking, Using a Computerized Task. Developmental Neuropsychology. 24(1). 461–477. 11 indexed citations
15.
O’Tuathaigh, Colm & Paula M. Moran. (2002). Evidence for dopamine D 1 receptor involvement in the stimulus selection task: overshadowing in the rat. Psychopharmacology. 162(3). 225–231. 21 indexed citations
16.
McDonald, Louise, Paula M. Moran, Goparlen N. Vythelingum, et al.. (2002). Latent inhibition is attenuated by noise and partially restored by a 5-HT2A receptor antagonist. Behavioural Pharmacology. 13(8). 663–667. 24 indexed citations
17.
McDonald, Louise, Paula M. Moran, M. H. Joseph, John Stephenson, & J.A. Gray. (2000). Two 5-HT2A antagonists enhance latent inhibition only when given at two stages of the paradigm. European Journal of Neuroscience. 12. 101–101. 1 indexed citations
18.
Moser, Paul, Paula M. Moran, Robert Frank, & John H. Kehne. (1995). Reversal of amphetamine-induced behaviours by MDL 100,907, a selective 5-HT2A antagonist. Behavioural Brain Research. 73(1-2). 163–167. 92 indexed citations
19.
Allain, H., et al.. (1989). Pregnancy and Parkinsonism A Case Report Without Problem. Clinical Neuropharmacology. 12(3). 217–219. 19 indexed citations
20.
Monkhouse, W. S., et al.. (1988). The histological effects on the guinea pig external ear of several constituents of commonly used aural preparations. Clinical Otolaryngology. 13(2). 121–131. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tori L. Schaefer Breakdown of academic impact, for papers by Roberto Stancampiano Breakdown of academic impact, for papers by Stacy A. Castner Breakdown of academic impact, for papers by Susana Mingote Breakdown of academic impact, for papers by Takeshi Izumi Breakdown of academic impact, for papers by Nader D. Halim Breakdown of academic impact, for papers by Gary Gilmour Breakdown of academic impact, for papers by Changhai Cui Breakdown of academic impact, for papers by Samantha E. Yohn Breakdown of academic impact, for papers by Luigi Pulvirenti
Rankless by CCL
2026